Authorship：Lead author   Language：Japanese   Publishing type：Research paper (scientific journal)  

researchmap

Language：Japanese   Publishing type：Research paper (scientific journal)  

researchmap

Language：Japanese   Publishing type：Research paper (scientific journal)  

researchmap

Language：Japanese   Publishing type：Research paper (scientific journal)  

researchmap

Language：Japanese   Publishing type：Research paper (scientific journal)  

researchmap

Language：Japanese   Publishing type：Research paper (scientific journal)  

researchmap

Language：English   Publishing type：Research paper (scientific journal)  

BACKGROUND: Colchicine binds to intracellular tubulin and prevents mitosis. Colchicine is also used as an anti-inflammatory drug. Meanwhile, excess administration of medication or accidental ingestion of colchicine-containing plants can cause acute colchicine poisoning, which initially results in gastrointestinal effects that may be followed by multiorgan dysfunction. However, the mechanism of colchicine poisoning remains unclear, and there are no standard therapeutic strategies. AIMS: We focused on intestinal barrier function and attempted to reveal the underlying mechanism of colchicine poisoning using an animal model. METHODS: Colchicine was orally administered to C57Bl/6 mice. Then, we performed histopathological analysis, serum endotoxin assays, and intestinal permeability testing. Additionally, the LPS-TLR4 signaling inhibitor TAK-242 was intraperitoneally injected after colchicine administration to analyze the therapeutic effect. RESULTS: We observed villus height reduction and increased numbers of apoptotic cells in the gastrointestinal epithelium of colchicine-treated mice. Both intestinal permeability and serum endotoxin levels were higher in colchicine-treated mice than in control mice. Although colchicine-poisoned mice died within 25 h, those that also received TAK-242 treatment survived for more than 48 h. CONCLUSION: Colchicine disrupted intestinal barrier function and caused endotoxin shock. Therapeutic inhibition of LPS-TLR4 signaling might be beneficial for treating acute colchicine poisoning.

DOI： 10.1007/s10620-019-05729-w

PubMed

researchmap

Language：Japanese   Publishing type：Research paper (scientific journal)  

researchmap

Language：Japanese   Publishing type：Research paper (scientific journal)  

researchmap

Authorship：Lead author   Language：Japanese   Publishing type：Research paper (scientific journal)  

researchmap

Language：English   Publishing type：Research paper (scientific journal)  

BACKGROUND: Hypothermia, either therapeutically induced or accidental (ie, an involuntary decrease in core body temperature to <35°C), results in hemostatic disorders. However, it remains unclear whether hypothermia enhances or inhibits coagulation, especially in severe hypothermia. The present study evaluated the thrombocytic and hemostatic changes in hypothermic mice. METHODS: C57Bl/6 mice were placed at an ambient temperature of -20°C under general anesthesia. When the rectal temperature decreased to 15°C, 10 mice were immediately euthanized, while another 10 mice were rewarmed, kept in normal conditions for 24 hours, and then euthanized. These treatments were also performed in 20 splenectomized mice. RESULTS: The hypothermic mice had adhesion of CD62P-positive platelets with high expression of von Willebrand factor (vWF) in their spleens, while the status of the peripheral platelets was unchanged. Furthermore, the plasma levels of platelet factor 4 (PF4) and pro-platelet basic protein (PPBP), which are biomarkers for platelet degranulation, were significantly higher in hypothermic mice than in control mice, indicating that hypothermia activated the platelets in the splenic pool. Thus, we analyzed these biomarkers in asplenic mice. There was no increase in either PF4 or PPBP in splenectomized hypothermic mice. Additionally, the plasma D-dimer elevation and microthrombosis were caused in rewarmed mice, but not in asplenic rewarmed mice. CONCLUSIONS: Our results indicate that hypothermia leads to platelet activation in the spleen via the upregulation of vWF, and this activation causes hypercoagulability after rewarming.

DOI： 10.1111/jth.14555

PubMed

researchmap

Language：English   Publishing type：Research paper (scientific journal)  

In hepatocarcinogenesis induced by diethylnitrosamine (DEN) in B6C3F1 mice, the BrafV637E mutation, corresponding to the human BRAFV600E mutation, plays a pivotal role. The livers of transgenic mice with a hepatocyte-specific human BRAFV600E mutation weighed 4.5 times more than that of normal mice and consisted entirely of hepatocytes, resembling DEN-induced preneoplastic hepatocytes. However, these transgenic mice spontaneously died 7 wk after birth, therefore this study aimed to clarify the causes of death. In the transgenic mice, the liver showed thrombopoietin (TPO) overexpression, which is associated with eventual megakaryocytosis and thrombocytosis, and activated platelets were deposited in hepatic sinusoids. TPO was also overexpressed in the DEN-induced hepatic tumors, and sinusoidal platelet deposition was observed in the hepatic tumors of humans and mice. Podoplanin was expressed in some of the Kupffer cells in the liver of the transgenic mice, indicating that platelet activation occurred via the interaction of podoplanin with C-type lectin receptor 2 (CLEC-2) on the platelet membrane. Additionally, erythrocyte dyscrasia and glomerulonephropathy/interstitial pneumonia associated with platelet deposition were observed. In the transgenic mice, aspirin (Asp) administration prevented platelet activation, reduced the liver/body weight ratio, decreased the platelet deposition in the liver, kidney, and lung, and prevented erythrocyte dyscrasia and ameliorated the renal/pulmonary changes. Thrombopoietin overproduction by BRAFV600E-mutated hepatocytes may contribute to hepatocyte proliferation via thrombocytosis, platelet activation, and the interaction of platelets with hepatic sinusoidal cells, while hematologic, renal, and pulmonary disorders due to aberrant platelet activation may lead to spontaneous death in the transgenic mice.

DOI： 10.1111/cas.14130

PubMed

researchmap

Language：English   Publishing type：Research paper (scientific journal)  

Locked nucleic acid (LNA) has been widely used for various genetic analyses, and has many benefits, in terms of the specificity or sensitivity of amplification, because LNA-containing primers/probes form more stable duplexes with template DNA than probes lacking LNA. Here, we developed a new method for discriminating HV1 haplotypes from mitochondrial DNA (mtDNA) mixtures by applying PCR clamping using LNA. PCR clamping is based on the selective inhibition of amplification using LNA-containing probes, which can discriminate single-nucleotide differences. Before designing probes, we selected 171 sequences with single-nucleotide variations from the HV1 region, and evaluated the specificity of LNA-containing probes for them by predicting Tm values. The differences of Tm between mismatched and exactly matched probe-template duplexes depended markedly on the type of LNA nucleotides for discriminating single-nucleotide differences, and the cytosine LNA nucleotide at the site of variations in the probes was most effective to discriminate these differences. For mixture analysis, each probe targeted one or two variations (16209C, 16217C, 16257A/16261T, 16297C/16298C, 16304C, 16362C, or 16362T) that are particularly common in the Japanese population, and seven designed probes completely inhibited the amplification of exactly matched templates. We prepared mixed samples by mixing DNA from two individuals at a ratio of 1:9, 1:4, 1:1, 4:1, or 9:1, and then performed Sanger sequencing analysis after PCR clamping with each probe. Our method distinguished each haplotype at lower ratios from two-person mixtures, and enabled sensitive detection at 12 pg of total DNA including 600 copies of mtDNA. Moreover, we analyzed three-person mixtures with representative sequences, and detected the minor haplotype of one individual present at a rate of 10% by adding two selected probes. The ability to discriminate haplotypes in mixed samples by using LNA-mediated PCR clamping indicates the potential value of mtDNA analysis in criminal investigations.

DOI： 10.1016/j.fsigen.2019.03.018

PubMed

researchmap

Language：English   Publishing type：Research paper (scientific journal)  

Bisphenol A (BPA), recognized as an endocrine disruptor, is thought to exert its activity through a mechanism involving the activation of estrogen receptors (ERs) α/β However, a major problem is that very high concentrations of BPA are required (i.e., those in excess of environmental levels) for effective activation of ERα/β-mediated transcriptional activities in vitro, despite the BPA-induced estrogenic effects observed in vivo. To elucidate the causal reasons, we successfully identified a BPA metabolite, 4-methyl-2,4-bis(4-hydroxyphenyl)pent-1-ene (MBP), which exhibits highly potent estrogenic activity both in vivo and in vitro. We have focused on the biologic relationship between breast tumor promotion and MBP/BPA, because BPA is considered to be a human carcinogen owing to its breast tumor-promoting properties. In general, humans are exposed to many endocrine disruptors, including BPA. In the present study, we used the ERα/β-positive human breast cancer cell line MCF-7 as an experimental model to investigate the effects of repeated exposure to BPA/MBP at concentrations found in the environment on the expression of ERα/β and to determine the particular ER subtype involved. We demonstrated that repeated exposure to MBP, but not to BPA, significantly downregulated ERα protein expression and stimulated the proliferation of MCF-7 cells through the activation of ERβ-mediated signaling.

DOI： 10.1124/mol.118.114124

PubMed

researchmap

Language：English   Publishing type：Research paper (scientific journal)  

Several bisphenol A (BPA) analogues have been detected in environmental samples, foodstuffs, and/or human biological samples, and there is concern regarding their potential endocrine-disrupting effects. In this study, we characterized the agonistic and/or antagonistic activities of BPA and eight its analogues against human estrogen receptors (ERα/β), androgen receptor (AR), glucocorticoid receptor (GR), pregnane X receptor (PXR), and constitutive androstane receptor (CAR). All the test compounds, except for bisphenol P (BPP), showed both ERα and ERβ agonistic activities, with bisphenol AF (BPAF) being the most potent. On the other hand, BPAF and BPP showed ERα and ERβ antagonistic activities. Interestingly, their ER activities demonstrated a preference toward ERβ. All the test compounds, except for bisphenol S, showed AR antagonistic activities, with bisphenol E being the most potent. Weak GR antagonistic activities were also found in BPA and five its analogues. PXR agonistic activity was observed in the six compounds, with bisphenol Z being the most potent. Results of the CAR assay revealed that BPA and five its analogues acted as CAR inverse agonists. Taken together, these results suggested that BPA analogues demonstrate multiple effects via human nuclear receptors in a similar manner to BPA, and several analogues might have more potent endocrine-disrupting activity than does BPA.

DOI： 10.1016/j.tox.2018.12.001

PubMed

researchmap

Authorship：Lead author   Language：Japanese   Publishing type：Research paper (scientific journal)  

researchmap

Language：English   Publishing type：Research paper (scientific journal)  

We analyzed the degradation level of DNA from buccal cells under humid conditions using quantitative PCR analysis. Gauze samples with buccal cells were incubated for up to 12 months under three different conditions (25 °C/dry, 25 °C/humid, or 40 °C/humid). The degradation was evaluated based on two degradation ratios (129:41 and 305:41 bp). DNA degraded slowly under the 25 °C/humid condition, and significant differences in the two degradation ratios were detected between 25 °C/dry and 25 °C/humid conditions after 12 months. Moreover, the degradation rapidly progressed under the 40 °C/humid condition, and the two degradation ratios in this condition were much lower than those from 25 °C/dry and 25 °C/humid conditions after a short incubation period (3 months). To evaluate the effect of DNA repair on low-copy degraded DNA, degenerate oligonucleotide-primed PCR (DOP-PCR) was performed before short tandem repeats (STR) genotyping. As a standard DOP-PCR, we used a 22-base primer with 10 degenerate sequences (5'-CTCGAGNNNNNNNNNNATGTGG-3'), and additionally designed DOP-PCR primers with 2, 4, 6, or 8 locked nucleic acids (LNAs). When slightly degraded DNA (305:41-bp ratio = 0.60) was used, DOP-PCR significantly increased the fluorescent intensity and success rate of genotyping using Identifiler and Globalfiler kits. In particular, the reaction with four LNAs produced the highest value. However, such benefits were not observed in the analysis of moderately degraded DNA (305:41-bp ratio = 0.13). Although the recovery rates of STR profiles by DOP-PCR were dependent on the degradation level of low-copy DNA, the effectiveness of DOP-PCR highlights the potential of LNA for degenerate sequences.

DOI： 10.1016/j.legalmed.2018.09.005

PubMed

researchmap

Language：English   Publishing type：Research paper (scientific journal)  

Paraquat (PQ) is a widely used herbicide in the world despite being highly toxic to humans. PQ causes fatal damage to multiple organs, especially the lungs. While oxidative stress is the main toxic mechanism of PQ, there is no established standard therapy for PQ poisoning. In this study, we investigated the cytoprotective effect of 4-phenylbutyrate (4PBA) on PQ toxicity in human lung adenocarcinoma A549 cells. Phosphorylation levels of major survival signaling kinases Akt and ERK, as well as expression levels of antioxidant enzymes catalase and superoxide dismutase 2 (SOD2) were examined. The cytoprotective mechanism of 4PBA against PQ was compared with the antioxidant reagent trolox. We demonstrated that both 4PBA and trolox attenuated PQ toxicity, but their mechanisms were different. 4PBA increased ERK2 phosphorylation levels, which could be inhibited by the PI3K inhibitor LY294002. The cytoprotective effect of 4PBA was also inhibited by LY294002. Catalase expression levels were increased by 4PBA, although this increase was not inhibited by LY294002. 4PBA did not increase SOD2 expression. Trolox did not affect phosphorylation of Akt or ERK, or the expression of antioxidant enzymes. These results suggest that 4PBA attenuated PQ cytotoxicity by ERK2 activation via PI3K. Our study may provide new findings for understanding the molecular mechanism underlying cytoprotection by 4PBA, as well as new therapeutic targets for PQ poisoning.

DOI： 10.1016/j.bbrc.2018.06.080

PubMed

researchmap

Language：English   Publishing type：Research paper (scientific journal)   Publisher：Elsevier Inc.  

As aldehyde oxidase (AOX) plays an emerging role in drug metabolism, understanding its significance for drug–drug interactions (DDI) is important. Therefore, we tested 10 compounds for species-specific and substrate-dependent differences in the inhibitory effect of AOX activity using genetically engineered HEK293 cells over-expressing human AOX1, mouse AOX1 or mouse AOX3. The IC50 values of 10 potential inhibitors of the three AOX enzymes were determined using phthalazine and O6-benzylguanine as substrates. 17β-Estradiol, menadione, norharmane and raloxifene exhibited marked differences in inhibitory effects between the human and mouse AOX isoforms when the phthalazine substrate was used. Some of the compounds tested exhibited substrate-dependent differences in their inhibitory effects. Docking simulations with human AOX1 and mouse AOX3 were conducted for six representative inhibitors. The rank order of the minimum binding energy reflected the order of the corresponding IC50 values. We also evaluated the potential DDI between an AOX substrate (O6-benzylguanine) and an inhibitor (hydralazine) using chimeric mice with humanized livers. Pretreatment of hydralazine increased the maximum plasma concentration (Cmax) and the area under the plasma concentration-time curve (AUC0–24) of O6-benzylguanine compared to single administration. Our in vitro data indicate species-specific and substrate-dependent differences in the inhibitory effects on AOX activity. Our in vivo data demonstrate the existence of a DDI which may be of relevance in the clinical context.

DOI： 10.1016/j.bcp.2018.04.017

Scopus

PubMed

researchmap

Language：English   Publishing type：Research paper (scientific journal)  

Electrical injury is damage caused by an electrical current passing through the body. We have previously reported that irregular stripes crossing skeletal muscle fibers (python pattern) and multiple small nuclei arranged in the longitudinal direction of the muscle fibers (chained nuclear change) are uniquely observed by histopathological analysis in the skeletal muscle tissues of patients with electrical injury. However, it remains unclear whether these phenomena are caused by the electrical current itself or by the joule heat generated by the electric current passing through the body. To clarify the causes underlying these changes, we applied electric and heat injury to the exteriorized rat soleus muscle in situ. Although both the python pattern and chained nuclear change were induced by electric injury, only the python pattern was induced by heat injury. Furthermore, a chained nuclear change was induced in the soleus muscle cells by electric current flow in physiological saline at 40 °C ex vivo, but a python pattern was not observed. When the skeletal muscle was exposed to electrical injury in cardiac-arrested rats, a python pattern was induced within 5 h after cardiac arrest, but no chained nuclear change was observed. Therefore, a chained nuclear change is induced by an electrical current alone in tissues in vital condition, whereas a python pattern is caused by joule heat, which may occur shortly after death. The degree and distribution of these skeletal muscle changes may be useful histological markers for analyzing cases of electrical injury in forensic medicine.

DOI： 10.1016/j.legalmed.2017.11.001

PubMed

researchmap

Language：English   Publishing type：Research paper (scientific journal)  

Tributyltin (TBT), a common organotin environmental pollutant, has been widely used as a component of marine antifouling paints. We previously reported that exposure to TBT inhibits the expression and DNA binding of nuclear respiratory factor-1 (NRF-1) and causes neurotoxicity. In the present study, we focused on the epigenetic effects of TBT and investigated whether TBT decreases NRF-1 expression via epigenetic modifications in SH-SY5Y human neuroblastoma cells. First, we found that exposure to 300 nM TBT decreases NRF-1 expression. We examined epigenetic changes induced by TBT, and showed that TBT causes hypermethylation of the NRF-1 promoter region, increases the amount of methyl-CpG-binding protein 2 (MeCP2) bound to the NRF-1 promoter, and alters the expression of DNA methyltransferases and ten-eleven translocation (TET) demethylation enzymes. These results suggest that epigenetic changes play an important role in regulation of NRF-1 expression. Next, we investigated effect of NRF-1 expression decrease on cells, and TBT reduces mitochondrial membrane potential and overexpression of NRF-1 rescued this reduction in membrane potential. Thus, we suggested that NRF-1 is important for maintaining mitochondrial membrane potential. Our study indicates that TBT causes epigenetic changes such as hypermethylation, which increases recruitment of MeCP2 to the NRF-1 promoter and probably lead to decreased of NRF-1 expression and mitochondrial membrane potential. Therefore, this research provides new evidence of the epigenetic action caused by organotin.

DOI： 10.1039/c7mt00290d

PubMed

researchmap

Language：English   Publishing type：Research paper (scientific journal)  

Being a stable metabolite of hydrogen sulfide, thiosulfate has been utilized as an index for hydrogen sulfide poisoning (HSP). Thiosulfate analysis is mainly performed using gas chromatography/mass spectrometry (GC-MS) due to its high sensitivity and specificity. The GC-MS analysis requires two-step derivatizations of thiosulfate, and the derivative is not stable in solution as it has a disulfide moiety. To resolve this stability issue, we developed a novel analytical method using liquid chromatography-tandem mass spectrometry (LC-MS/MS) for monitoring the pentafluorobenzyl derivative of thiosulfate (the first reaction product of the GC-MS method) in this study. The established method exhibited high reproducibility despite being a more simplified and rapid procedure compare to the GC-MS method. Phenyl 4-hydroxybenzoate was used as an internal standard because 1,3,5-tribromobenzene which had been used in the GC-MS method was not suitable compound for LC-MS/MS with Electrospray ionization (ESI) negative detection. The linear regression of the peak area ratios versus concentrations was fitted over the concentration ranges of 0.5-250μM and 0.25-250μM in blood and urine, respectively. The validation results satisfied the acceptance criteria for intra- and inter-day accuracy and precision. Blood and urine samples from 12 suspected HSP cases were tested using this method. The thiosulfate concentration detected in the sample coincided well with that determined at the scene of each HSP accident.

DOI： 10.1016/j.legalmed.2016.12.004

PubMed

researchmap

Language：Japanese   Publishing type：Research paper (scientific journal)  

researchmap

Authorship：Lead author   Language：Japanese   Publishing type：Research paper (scientific journal)  

researchmap

Language：Japanese   Publishing type：Research paper (scientific journal)  

researchmap

Language：English   Publishing type：Research paper (scientific journal)  

Blood and tissue samples from a forensic autopsy of a man in his late 60s, who developed dementia and died of multiple head traumas due to a fall from a moving vehicle, contained certain amounts of n-butane and i-butane. The concentration of n-butane was in the range of 0.48-70.5 μL/g, which would be considered as toxic or lethal levels. We had to distinguish whether the cause of his unexplained behavior was due to his pre-existing condition (dementia), or from a confused state induced by butane abuse. No traces of butane use were found at the scene. Police investigation revealed that a propellant used in an anticontagious plugging spray had been administered to him during a postmortem treatment in the emergency hospital. In order to prove the postmortem butane diffusion had resulted from the spray administration and to estimate the diffused concentration, experimental simulation was conducted by using rats. As a result of postmortem treatment with the spray, n-butane at concentrations of 0.54-15.5 μL/mL or g were found in the rat blood and tissues. In this case, we provided further evidence that the postmortem butane diffusion, caused by using the anticontagious plugging spray containing butane gas as a propellant administered to a cadaver during a postmortem procedure prior to forensic autopsy, should be distinguished from cases of actual butane poisoning.

DOI： 10.1016/j.legalmed.2015.08.003

PubMed

researchmap

Language：English   Publishing type：Research paper (scientific journal)  

The aim of this study was to develop a cost-effective genotyping method using high-quality DNA for human identification. A total of 21 short tandem repeats (STRs) and amelogenin were selected, and fluorescent fragments at 22 loci were simultaneously amplified in a single-tube reaction using locus-specific primers with 24-base universal tails and four fluorescent universal primers. Several nucleotide substitutions in universal tails and fluorescent universal primers enabled the detection of specific fluorescent fragments from the 22 loci. Multiplex polymerase chain reaction (PCR) produced intense FAM-, VIC-, NED-, and PET-labeled fragments ranging from 90 to 400 bp, and these fragments were discriminated using standard capillary electrophoretic analysis. The selected 22 loci were also analyzed using two commercial kits (the AmpFLSTR Identifiler Kit and the PowerPlex ESX 17 System), and results for two loci (D19S433 and D16S539) were discordant between these kits due to mutations at the primer binding sites. All genotypes from the 100 samples were determined using 2.5 ng of DNA by our method, and the expected alleles were completely recovered. Multiplex 22-locus genotyping using four fluorescent universal primers effectively reduces the costs to less than 20% of genotyping using commercial kits, and our method would be useful to detect silent alleles from commercial kit analysis.

DOI： 10.1016/j.ab.2015.10.005

PubMed

researchmap

Language：English  

Although Kawasaki disease (KD) is a self-limiting disease, it may cause sudden cardiac death. Diagnosis of KD is principally based on clinical signs; however, some infant cases do not meet the criteria. Such cases are identified as incomplete KD. The sudden death risk in incomplete KD cases is similar to conventional KD. In our 5-month-old case, he had been admitted to a hospital for a fever and suppuration at the site of Bacille de Calmette et Guerin (BCG) vaccination. However, after discharge from the hospital, his C-reactive protein (CRP) levels declined, he got indisposed and died suddenly. A medico-legal autopsy revealed myocarditis, coronaritis, platelet-aggregated emboli in coronary arteries, and myocardial degeneration, suggesting that the fatal myocardial infarction was due to thrombus emboli in the coronary arteries. Forensic pathologists therefore should pay attention to the cardiac pathology originated from incomplete KD as a potential cause in cases of sudden infant death.

DOI： 10.1111/1556-4029.12929

PubMed

researchmap

Language：Japanese   Publishing type：Research paper (scientific journal)  

researchmap

Language：English   Publishing type：Research paper (scientific journal)  

We synthesized azo dye- and fluorescence-labeled cis-cinnamic acid analogues possessing inhibitory activity against lettuce root growth and a trans-isomer without bioactivity as a control probe. The radicles incubated with the azo dye-labeled analogue were stained red, with their tips especially deeply dyed. The fluorescent images of the radicles incubated with each of these molecular probes depicted that the root cap was fluorescence-stained. However, images of the control radicles prepared by staining with the trans-isomer fluorescent probe did not show emission at the root cap. These contrasts suggest specific localization of the cis-cinnamate analogue at the columella cells.

DOI： 10.1016/j.tet.2016.08.060

Scopus

researchmap

Language：Japanese   Publishing type：Research paper (scientific journal)  

researchmap

Language：English   Publishing type：Research paper (scientific journal)  

researchmap

Language：English   Publishing type：Research paper (scientific journal)  

DOI： 10.4172/jfpy.1000108

researchmap

Language：Japanese   Publishing type：Research paper (scientific journal)  

researchmap

Language：English   Publishing type：Research paper (scientific journal)  

Bongkrekic acid, isolated from Burkholderia cocovenenans, is known to specifically inhibit the mitochondrial ADP/ATP carrier. However, the manner of its interaction with the carrier remains elusive. In this study, we tested the inhibitory effects of 17 bongkrekic acid analogues, derived from the intermediates obtained during its total synthesis, on the mitochondrial ATP/ATP carrier. Rough screening of these chemicals, performed by measuring their inhibitory effects on the mitochondrial ATP synthesis, revealed that 4 of them, KH-1, KH-7, KH-16, and KH-17, had moderate inhibitory effects. Further characterization of the actions of these 4 analogues on mitochondrial function showed that KH-16 had moderate; KH-1 and KH-17, weak; and KH-7, negligible side effects of both permeabilization of the mitochondrial inner membrane and inhibition of the electron transport, indicating that only KH-7 had a specific inhibitory effect on the mitochondrial ADP/ATP carrier. Although the parental bongkrekic acid showed a strong pH dependency of its action, the inhibitory effect of KH-7 was almost insensitive to the pH of the reaction medium, indicating the importance of the 3 carboxyl groups of bongkrekic acid for its pH-dependent action. A direct inhibitory effect of KH-7 on the mitochondrial ADP/ATP carrier was also clearly demonstrated.

DOI： 10.1111/cbdd.12594

PubMed

researchmap

Language：English   Publishing type：Research paper (scientific journal)  

Analysis of oxyhemoglobin (O2-Hb) saturation levels in the left and right heart blood is useful in the assessment of exposure to cold surroundings before death. We quantified conventional subjective visual evaluation of O2-Hb saturation levels and developed useful diagnostic criteria for fatal hypothermia: O2-Hb saturation in the left heart blood (L-O2Hb) was ⩾36%, the O2-Hb saturation gap between the left and right heart blood (L-R gap) was ⩾13%, and the O2-Hb saturation ratio of the left to right heart blood (L/R ratio) was ⩾1.8. When we used L-O2Hb of ⩾36% as a basic criterion and applied a further criterion of an L-R gap of ⩾13% or an L/R ratio of ⩾1.8, these criteria registered a sensitivity level of ⩾86% and specificity level of ⩾93% for the diagnosis of fatal hypothermia. This method can be useful for determining fatal hypothermia in connection with conventional autopsy findings, as well as histological and biochemical markers.

DOI： 10.1016/j.legalmed.2015.09.005

PubMed

researchmap

Language：English   Publishing type：Research paper (scientific journal)  

Bongkrekic acid (BKA), isolated from the bacterium Burkholderia cocovenenans, is an inhibitor of adenine nucleotide translocator, which inhibits apoptosis, and is thus an important tool for the mechanistic investigation of apoptosis. An efficient total synthesis of BKA has been achieved by employing a three-component convergent strategy based on Kocienski-Julia olefination and Suzuki-Miyaura coupling. It is noteworthy that segment B has been prepared as a new doubly functionalized coupling partner, which contributes to shortening of the number of steps. Torquoselective olefination with an ynolate has also been applied for the efficient construction of an unsaturated ester. Furthermore, it is revealed that 1-methyl-2-azaadamantane N-oxyl is an excellent reagent for final oxidation to afford BKA in high yield. Based on the total synthesis, several BKA analogues were prepared for structure-activity relationship studies, which indicated that the carboxylic acid moieties were essential for the apoptosis inhibitory activity of BKA. More easily available BKA analogues with potent apoptosis inhibitory activity were also developed.

DOI： 10.1002/chem.201501304

PubMed

researchmap

Language：English   Publishing type：Research paper (scientific journal)  

Amplification of fluorescently labeled products is one of the most popular methods for genotyping genetic variations. Two-step amplification using fluorescent universal primers simultaneously produces multiple targeted fragments labeled with fluorescent dyes, and this strategy is applicable to large-scale, cost-effective genotyping. In this study, we developed a fast PCR-based, multiple short tandem repeat (STR) genotyping method using fluorescent universal primers containing locked nucleic acids (LNAs). Four amplification reactions, each assaying six or seven markers and using 0.5-1.0 ng of genomic DNA, produced obvious Fam-labeled peaks in all 26 loci tested (25 autosomal STRs and amelogenin). The overall amplification time was 37 min. Moreover, fluorescent signals for the 25 STRs obtained from LNA-containing primers were 1.5-9.0 fold higher compared to those from non-LNA primers. Using genomic DNA from 120 Japanese individuals, 16 out of the 25 STRs had observed heterozygosity greater than 0.7. Some of these 25 STRs also had high discriminatory power, similar to that of the 13 core STRs in the Combined DNA Index System dataset. The probability of incorrectly assigning a match based on the accumulated matching probability for these 25 STRs is 1.2 × 10(-22), and their combined use can provide robust information for Japanese forensics.

DOI： 10.1016/j.jflm.2015.01.004

PubMed

researchmap

Language：Japanese   Publisher：(公社)日本薬学会  

researchmap

Authorship：Lead author   Language：Japanese   Publishing type：Research paper (scientific journal)  

researchmap

Language：English   Publishing type：Research paper (scientific journal)   Publisher：ELSEVIER SCIENCE BV  

In vitro estimating strategies for potential neurotoxicity are required to screen multiple substances. In a previous study, we showed that exposure to low-concentrations of some chemicals, such as organotin, decreased the expression of GluR2 protein, which is a subunit of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionic acid (AMPA)-type glutamate receptors, and led to neuronal vulnerability. This result suggested that GluR2 decreases as an index of neuronal cell sensitivity and vulnerability to various toxic insults. Accordingly, we developed a versatile method that is a large scale determination of GluR2 protein expression in the presence of environmental chemicals by means of AlphaLISA technology. Various analytical conditions were optimized, and then GluR2 protein amount was measured by the method using AlphaLISA. The GluR2 amounts were strongly correlated with that of measured by western blotting, which is currently used to determine GluR2 expression. An ideal standard curve could be written with the authentic GluR2 protein from 0 ng to100 ng. Subsequently, twenty environmental chemicals were screened and nitenpyram was identified as a chemical which lead to decrease in Glu

DOI： 10.1016/j.toxrep.2014.12.014

PubMed

researchmap

Language：English   Publishing type：Research paper (scientific journal)   Publisher：JAPANESE SOC TOXICOLOGICAL SCIENCES  

Naturally occurring low-molecular weight compounds with a chemical structure like that of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine, such as 1-benzyl-1,2,3,4-tetrahydroisoquinoline (1BnTIQ), are candidates for the endogenous neurotoxins that cause Parkinson&#039;s disease (PD). 1BnTIQ is an endogenous amine in human CSF and increases in the CSF of patients with PD. It inhibits complex I and elicits PD-like behavioral abnormalities in monkey and mouse. In this study, we searched metabolites of 1BnTIQ by rat liver S9 using liquid chromatography-tandem mass spectrometry, and identified a dehydrated metabolite, 1-benzyl-3,4-dihydroisoquinoline (1BnDIQ). 1BnDIQ was identified by corresponding mass spectra and precursor ion scans in authentic and complete enzyme samples. Multiple reaction monitoring analysis showed microsome-dependent 1BnDIQ production. We previously reported that 1BnDIQ is more toxic than 1BnTIQ in cytotoxicity study in SH-SY5Y neuroblastoma cells. In addition, 1BnTIQ is reported to pass through the blood-brain barrier of the rat brain, and 1BnDIQ is supposed to be more lipophilic than 1BnTIQ. 1BnDIQ may easily reach the brain, and it might contribute to PD-related neurot

PubMed

researchmap

Language：English   Publishing type：Research paper (scientific journal)   Publisher：Wiley  

Parkinson's disease (PD) is a common neurodegenerative disease, but its pathogenesis remains elusive. A mutation in ubiquitin C-terminal hydrolase L1 (UCH-L1) is responsible for a form of genetic PD which strongly resembles the idiopathic PD. We previously showed that 1-(3',4'-dihydroxybenzyl)-1,2,3,4-tetrahydroisoquinoline (3',4'DHBnTIQ) is an endogenous parkinsonism-inducing dopamine derivative. Here, we investigated the interaction between 3',4'DHBnTIQ and UCH-L1 and its possible role in the pathogenesis of idiopathic PD. Our results indicate that 3',4'DHBnTIQ binds to UCH-L1 specifically at Cys152 in vitro. In addition, 3',4'DHBnTIQ treatment increased the amount of UCH-L1 in the insoluble fraction of SH-SY5Y cells and inhibited its hydrolase activity to 60%, reducing the level of ubiquitin in the soluble fraction of SH-SY5Y cells. Catechol-modified UCH-L1 as well as insoluble UCH-L1 were detected in the midbrain of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-treated PD model mice. Structurally as well as functionally altered UCH-L1 have been detected in the brains of patients with idiopathic PD. We suggest that conjugation of UCH-L1 by neurotoxic endogenous compounds such as 3',4'DHBnTIQ might play a key role in onset and progression of idiopathic PD. We investigated the interaction between ubiquitin C-terminal hydrolase L1 (UCH-L1) and the brain endogenous parkinsonism inducer 1-(3',4'-dihydroxybenzyl)-1,2,3,4-tetrahydroisoquinoline (3',4'DHBnTIQ). Our results indicate that 3',4'DHBnTIQ binds to UCH-L1 specifically at cysteine 152 and induces its aggregation. 3',4'DHBnTIQ also inhibits the hydrolase activity of UCH-L1. Catechol-modified as well as insoluble UCH-L1 were detected in the midbrains of MPTP-treated Parkinson's disease (PD) model mice. Conjugation of UCH-L1 by neurotoxic endogenous compounds like 3',4'DHBnTIQ might play a key role in onset and progression of PD.

DOI： 10.1111/jnc.12762

PubMed

researchmap

Language：English   Publishing type：Research paper (scientific journal)  

The activity of cis-cinnamic acid (cis-CA), one of the allelochemicals, in plants is very similar to that of indole-3-acetic acid (IAA), a natural auxin, and thus cis-CA has long been believed to be an analog of auxin. We have reported some structure-activity relationships studies by synthesizing over 250 cis-CA derivatives and estimating their inhibitory activities on root growth inhibition in lettuce. In this study, the compounds that showed low- or no-activity on root growth inhibition were recruited as candidates suppressors against cis-CA and/or auxin and tested for their activity. In the presence of cis-CA, lettuce root growth was inhibited; however, the addition of some cis-CA derivatives restored control-level root growth. Four compounds, (Z)-3-(4-isopropylphenyl)acrylic acid, (Z)-3-(3-butoxyphenyl)acrylic acid, (Z)-3-[3-(pentyloxy)phenyl]acrylic acid, and (Z)-3-(naphthalen-1-yl)acrylic acid were selected as candidates for a cis-CA selective suppressor they allowed the recovery of root growth from inhibition by cis-CA treatment without any effects on the IAA-induced effect or elongating activity by themselves. Three candidates significantly ameliorated the root shortening by the potent inhibitor derived from cis-CA. In brief, we have found some cis-CA selective suppressors which have never been reported from inactive cis-CA derivatives for root growth inhibition. cis-CA selective suppressors will play an important role in elucidating the mechanism of plant growth regulation.

PubMed

researchmap

Language：English   Publishing type：Research paper (scientific journal)  

researchmap

Language：English   Publishing type：Research paper (scientific journal)  

researchmap

Language：English   Publishing type：Research paper (scientific journal)  

Bisphenol A (BPA) is a widely used plastics constituent that has been associated with endocrine, immune and metabolic effects. Evidence for how BPA exerts significant biological effects at chronic low levels of exposure has remained elusive. In adult men, exposure to BPA has been associated with higher expression of two nuclear receptors, oestrogen receptor-β (ERβ) and oestrogen-related-receptor-α (ERRα), in peripheral white blood cells in vivo. In this study, we explore the expression of ESR2 (ERβ) and ESRRA (ERRα) in human leukaemic T-cell lymphoblasts (Jurkat cells) exposed to BPA in vitro. We show that exposure to BPA led to enhanced expression of ESRRA within 6 h of exposure (mean±s.e.m.: 1.43±0.08-fold increase compared with the control, P<0.05). After 72 h, expression of ESRRA remained significantly enhanced at concentrations of BPA ≥1 nM. Oxidative metabolism of BPA by rat liver S9 fractions yields the potent oestrogenic metabolite, 4-methyl-2,4-bis(4-hydroxyphenyl)pent-1-ene (MBP). Exposure of cells to 1-100 nM MBP increased the expression of both ESRRA (significantly induced, P<0.05, at 1, 10, 100 nM) and ESR2 (1.32±0.07-fold increase at 100 nM exposure, P<0.01). ERRα is a major control point for oxidative metabolism in many cell types, including T-cells. Following exposure to both BPA and MBP, we found that cells showed a decrease in cell proliferation rate. Taken together, these results confirm the bioactivity of BPA against putative T-cell targets in vitro at concentrations relevant to general human exposure.

DOI： 10.1530/REP-13-0423

PubMed

researchmap

Language：English   Publishing type：Research paper (scientific journal)  

researchmap

Language：English   Publishing type：Research paper (scientific journal)  

1-O-cis-Cinnamoyl-β-D-glucopyranose is one of the most potent allelochemicals that has been isolated from Spiraea thunbergii Sieb by Hiradate et al. It derives its strong inhibitory activity from cis-cinnamic acid (cis-CA), which is crucial for phytotoxicity. By preparing and assaying a series of cis-CA analogues, it was previously found that the key features of cis-CA for lettuce root growth inhibition are a phenyl ring, cis-configuration of the alkene moiety, and carboxylic acid. On the basis of a structure-activity relationship study, the substituent effects on the aromatic ring of cis-CA were examined by systematic synthesis and the lettuce root growth inhibition assay of a series of cis-CA analogues having substituents on the aromatic ring. While ortho- and para-substituted analogues exhibited low potency in most cases, meta-substitution was not critical for potency, and analogues having a hydrophobic and sterically small substituent were more likely to be potent. Finally, several cis-CA analogues were found to be more potent root growth inhibitors than cis-CA.

DOI： 10.1016/j.phytochem.2013.08.013

PubMed

researchmap

Language：English   Publishing type：Research paper (scientific journal)  

1-O-cis-Cinnamoyl-β-D-glucopyranose is known to be one of the most potent allelochemical candidates and was isolated from Spiraea thunbergii Sieb by Hiradate et al. (2004), who suggested that it derived its strong inhibitory activity from cis-cinnamic acid, which is crucial for phytotoxicity. In this study, key structural features and substituent effects of cis-cinnamic acid (cis-CA) on lettuce root growth inhibition was investigated. These structure-activity relationship studies indicated the importance of the spatial relationship of the aromatic ring and carboxylic acid moieties. In this context, conformationally constrained cis-CA analogues, in which the aromatic ring and cis-olefin were connected by a carbon bridge, were designed, synthesized, and evaluated as plant growth inhibitors. The results of the present study demonstrated that the inhibitory activities of the five-membered and six-membered bridged compounds were enhanced, up to 0.27 μM, and were ten times higher than cis-CA, while the potency of the other compounds was reduced.

DOI： 10.1016/j.phytochem.2013.10.001

PubMed

researchmap

Language：English   Publishing type：Research paper (scientific journal)   Publisher：ACADEMIC PRESS INC ELSEVIER SCIENCE  

Organotin compounds, especially tributyltin chloride (TBT), have been widely used in antifouling paints for marine vessels, but exhibit various toxicities in mammals. The endoplasmic reticulum (ER) is a multifunctional organelle that controls post-translational modification and intracellular Ca2+ signaling. When the capacity of the quality control system of ER is exceeded under stress including ER Ca2+ homeostasis disruption, ER functions are impaired and unfolded proteins are accumulated in ER lumen, which is called ER stress. Here, we examined whether TBT causes ER stress in human neuroblastoma SH-SY5Y cells. We found that 700 nM TBT induced ER stress markers such as CHOP, GRP78, spliced XBP1 mRNA and phosphorylated eIF2 alpha. TBT also decreased the cell viability both concentration- and time-dependently. Dibutyltin and monobutyltin did not induce ER stress markers. We hypothesized that TBT induces ER stress via Ca2+ depletion, and to test this idea, we examined the effect of TBT on intracellular Ca2+ concentration using fura-2 AM, a Ca2+ fluorescent probe. TBT increased intracellular Ca2+ concentration in a TBT-concentration-dependent manner, and Ca2+ increase in 700 nM TBT was mainly blocked by 50 mu M dantrolene, a ryanodine receptor antagonist (about 70% inhibition). Dantrolene also partially but significantly inhibited TBT-induced GRP78 expression and cell death. These results suggest that TBT increases intracellular Ca2+ concentration by releasing Ca2+ from ER, thereby causing ER stress. (C) 2013 Elsevier Inc. All rights reserved.

DOI： 10.1016/j.taap.2013.05.026

Web of Science

PubMed

researchmap

Language：English   Publishing type：Research paper (scientific journal)  

The fact that mitochondrial dysfunction has been implicated in a variety of human diseases suggests that they would be expected as a target organelle for these diseases. Bongkrekic acid (BKA) is a chemical that functions as a ligand of the adenine nucleotide translocator and is known to potently inhibit the mitochondrial permeability transition that is associated with apoptosis. Thus, delivering it to mitochondria would be an innovative therapy for the treatment of mitochondrial diseases that are largely associated with apoptosis. Here, we report on the use of a MITO-Porter, an innovative nanocarrier for mitochondrial delivery via mitochondrial membrane fusion, for delivering BKA to mitochondria. We first constructed a BKA-MITO-Porter, in which BKA is contained in lipid envelopes of a MITO-Porter. We then confirmed that the BKA-MITO-Porter was efficiently internalized into cells and is delivered to mitochondria, similar to a conventional MITO-Porter. Moreover, we evaluated the antiapoptosis effect of the BKA-MITO-Porter in HeLa cells by measuring caspase 3/7 activity. The findings confirmed that the BKA-MITO-Porter showed a strong antiapoptosis effect compared with naked BKA. The results reported here demonstrate its potential for the use in therapies aimed at mitochondrial diseases, as a mitochondrial medicine candidate.

DOI： 10.1002/jps.23442

PubMed

researchmap

Language：English   Publishing type：Research paper (scientific journal)  

cis-Cinnamoyl glucosides are the allelochemicals in Thunberg's meadowsweet (Spiraea thunbergii). The essential chemical structure responsible for the bioactivity of cis-cinnamoyl glucosides, cis-cinnamic acid (cis-CA), strongly inhibits the root growth of several plant species; however, its mode of action has not been characterized at the gene expression level. We conducted a time-course microarray analysis of gene expression in Arabidopsis in response to 20 μM cis-CA. Comparison of the microarray profiles revealed a 10-fold upregulation of several auxin-responsive GRETCHEN HAGEN-3 (GH3) genes and LATERAL ORGAN BOUNDARIES DOMAIN/ASYMMETRIC LEAVES2-LIKE (LBD) genes from 2 h to 6 h post-treatment. Two early auxin-responsive gene families, the Aux/IAA family (IAA1, IAA5) and the GH3 family (GH3.1, GH3.2, GH3.3), and an LBD gene (LBD16) were markedly upregulated at 2 h after treatment in the roots, but not in the shoots, of Arabidopsis and remained highly expressed for 4 h. The influence of an exogenous application of cis-CA on the indole-3-acetic acid pathway strongly suggests that a root-targeted induction of auxin-responsive genes is involved in the cis- CA-mediated plant growth inhibition. © 2013 The Japanese Society for Plant Cell and Molecular Biology.

DOI： 10.5511/plantbiotechnology.13.0781a

researchmap

Language：English   Publishing type：Research paper (scientific journal)  

1-O-cis-cinnamoyl-β-D-glucopyranose is one of the most potent allelochemicals isolated from Spiraea thunbergii Sieb. It is suggested that it derives its strong inhibitory activity from cis-cinnamic acid, which is crucial for phytotoxicity. It was synthesized to confirm its structure and bioactivity, and also a series of cis-cinnamic acid analogues were prepared to elucidate the key features of cis-cinnamic acid for lettuce root growth inhibition. The cis-cyclopropyl analogue showed potent inhibitory activity while the saturated and alkyne analogues proved to be inactive, demonstrating the importance of the cis-double bond. Moreover, the aromatic ring could not be replaced with a saturated ring. However, the 1,3-dienylcyclohexene analogue showed strong activity. These results suggest that the geometry of the C-C double bond between the carboxyl group and the aromatic ring is essential for potent inhibitory activity. In addition, using several light sources, the photostability of the cinnamic acid derivatives and the role of the C-C double bond were also investigated.

DOI： 10.1016/j.phytochem.2012.08.001

PubMed

researchmap

Language：English   Publishing type：Research paper (scientific journal)  

Bongkrekic acid (BKA) is an inhibitor of adenine nucleotide translocase (ANT). Since inhibition of ANT is connected to the inhibition of cytochrome c release from mitochondria, which then results in the suppression of apoptosis, it has been used as a tool for the mechanistic investigation of apoptosis. BKA consists of a long carbon chain with two asymmetric centers, a nonconjugated olefin, two conjugated dienes, three methyl groups, a methoxyl group, and three carboxylic acids. This complicated chemical structure has caused difficulties in synthesis, supply, and biochemical mechanistic investigations. In this study, we designed and synthesized more simple tricarboxylic acids that were inspired by the molecular structure of BKA. Their cytotoxicity and apoptosis-preventing activity in HeLa cells and the effect on the mitochondrial inner membrane potential (ΔΨm) in HL-60 cells were then evaluated. All tested tricarboxylic acid derivatives including BKA showed little toxicity against HeLa cells. BKA and two of the synthesized derivatives significantly suppressed staurosporine (STS)-induced reductions in cell viability. Furthermore, STS-induced ΔΨm collapse was significantly restored by pretreatment with BKA and a tricarboxylic acid derivative. Other derivatives, in which one of three carboxylic acids was esterified, exhibited potent toxicity, especially a derivative bearing a carbon chain of the same length as that of BKA. In conclusion, we have developed a new lead compound as an apoptosis inhibitor bearing three carboxylic acids connected with the proper length of a long carbon chain.

DOI： 10.1021/tx300315h

PubMed

researchmap

Language：English   Publishing type：Research paper (scientific journal)  

We previously demonstrated that estrogenic activity of bisphenol A (BPA) in the yeast estrogen screening assay was increased severalfold after incubation with rat liver S9 fraction in the presence of a NADPH-generating system. In this study, we investigated whether eight BPA-related compounds are similarly activated metabolically by rat liver S9 fraction. Three of the analogs exhibited an increase of estrogenic activity after incubation with rat liver S9 fraction but not with microsomal or cytosolic fraction alone. The structures of the metabolites formed were examined by liquid chromatography/mass spectrometry. In addition to oxidized metabolites such as catechols, we found novel dimer-type metabolites. Some of the putative metabolites were chemically synthesized to confirm their structures. The structural requirements for formation of the metabolites, some of which showed more potent estrogenic activity than the parent substrates, were examined. We have uncovered a new pathway of metabolic activation of certain phenolic compounds, such as BPA analogs, to estrogenic dimer-type compounds.

DOI： 10.1124/dmd.111.040121

PubMed

researchmap

Language：English   Publishing type：Research paper (scientific journal)  

4-Methyl-2,4-bis(4-hydroxyphenyl)pent-1-ene (MBP), an active metabolite of bisphenol A (BPA), has more potent estrogenic activity than BPA in vitro, but its activity in vivo is not established. Here, we examined in vivo estrogenic activity of MBP by means of uterotrophic assay in ovariectomized (OVX) female rats. MBP exhibited dose-dependent estrogenic activity, as evaluated in terms of effects on uterus weight, uterine luminal epithelial cell height and myometrium thickness. The highest concentration of MBP (10 mg/kg/day) completely reversed the changes caused by OVX, and its activity was equivalent to that of 5 microg/kg/day 17beta-estradiol (E2). We also investigated the effects of MBP on transcription of several estrogen-related genes. The changes of mRNA levels of estrogen receptors alpha and beta, c-fos and insulin-like growth factor 1 in MBP-treated OVX rats were qualitatively similar to those in E2-treated rats. BPA did not show any significant effect on OVX rat in these conditions. This study is the first to demonstrate that MBP, an active metabolite of BPA, has potent in vivo estrogenic activity, being about 500-fold more potent than BPA in OVX rats.

DOI： 10.1016/j.toxlet.2010.04.017

PubMed

researchmap

Language：English   Publisher：The Pharmaceutical Society of Japan  

Transmissible spongiform encephalopathies (TSEs) are a family of invariably fatal neurodegenerative diseases. This group includes scrapie in sheep, bovine spongiform encephalopathy (BSE) in cattle, chronic wasting disease (CWD) in cervids, and Creutzfeldt-Jakob disease (CJD) in humans. These diseases are characterized by the accumulation of the abnormal isoform prion protein (PrP^Sc), which is a misfolded version of the cellular prion protein (PrP^C) and is resistant to enzymatic degradation. Numerous compounds have been reported to inhibit prion replication and PrP^Sc accumulation in cell cultures. Among them, we selected 2,2'-biquinoline (BQ) and studied the mechanism of its anti-prion disease activity. Its effect on prion protein (PrP) expression was examined in mouse neuroblastoma (N2a) cells and in prion-infected N2a (ScN2a) cells, using proteinase K (PK) treatment to discriminate between PrP^C and PrP^Sc. We found that BQ time dependently decreased the total amount of PrP and PrP mRNA expression in infected N2a cells, but not uninfected N2a cells. Our results indicate that the inhibition of PrP^Sc production by BQ was due to a decrease in the total amount of PrP.

DOI： 10.1248/jhs.55.586

CiNii Books

researchmap

Other Link： https://jlc.jst.go.jp/DN/JALC/00334539603?from=CiNii

Language：English   Publishing type：Research paper (scientific journal)   Publisher：ELSEVIER SCIENCE BV  

Since the first report that 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine induces parkinsonism, various kinds of low-molecular-weight neurotoxins, such as tetrahydroisoquinoline derivatives, have been identified as possible Parkinson&apos;s disease-inducing substances. In the present study, we measured four parameters of 17 tetrahydroisoquinoline derivatives, i.e., cytotoxicity in SH-SY5Y human neuroblastoma cells, inhibitory activity towards mitochondrial NADH-ubiquinone oxidoreductase (complex I), affinity for dopamine transporter, and 1-butanol-H(2)O partition coefficient (as an index of lipophilicity). Six of the derivatives showed comparatively strong inhibitory activity towards complex I (IC(50) values &lt; 100 mu M) and five of them were cytotoxic to SH-SY5Y cells (TC(50) values &lt; 200 mu M). Some of these compounds are endogenous. We found good correlations between cytotoxicity and complex I inhibitory activity, but not between cytotoxicity and affinity for dopamine transporter. Since cytotoxicity to SH-SY5Y neuroblastoma cells was related to inhibitory activity towards mitochondrial complex I, complex I inhibition is likely to be involved, at least in part, in the mechanism of TIQ derivative-induced cell death. Uptake of most of these compounds seems to be dependent on lipophilicity, rather than active transport via dopamine transporter. (c) 2006 Elsevier Inc. All rights reserved.

DOI： 10.1016/j.neuro.2006.06.002

Web of Science

PubMed

researchmap

Language：English   Publishing type：Research paper (scientific journal)   Publisher：PHARMACEUTICAL SOC JAPAN  

1-Methyl-1,2,3,4-tetrahydroisoquinoline (1MeTIQ), an endogenous parkinsonism-preventing substance, and its 5-, 6-, and 7-hydroxylated derivatives are reported to show in vitro neuroprotective activity against toxicity due to salsolinol in SH-SY5Y human neuroblastoma cells. In the present study, we tested the parkinsonism-preventing potential of these derivatives by means of the pole test in C57BL mice in vivo, and measured brain dopamine contents by liquid chromatography-tandem mass spectrometry. Parkinsonism was induced by 1-methyl-4-phenyl-1,2,3,6-tetrahydroisoquinoline(MPTP), and pretreatment with any of the 1MeTIQ derivatives prevented its induction. 6-Hydroxy-1MeTIQ showed the greatest preventive activity. The amount of dopamine in the brain was reduced by MPTP treatment, and this reduction was suppressed by pretreatment with 1MeTIQ derivatives. These hydroxy-1MeTIQ derivatives may have potential for the treatment of Parkinson's disease as well as 1MeTIQ itself.

DOI： 10.1248/bpb.29.1401

Web of Science

PubMed

researchmap

Language：English   Publishing type：Research paper (scientific journal)   Publisher：ELSEVIER  

1-Methyl-1,2,3,4-tetrahydroisoquinoline (1MeTIQ) is an endogenous brain amine and its content in parkinsonian brain is decreased compared with that in control brain. There is some evidence that 1MeTIQ protects dopaminergic neurons against dysfunction such as that seen in Parkinson's disease. In this study, we examined the neuroprotective effect of 1MeTIQ against four dopaminergic neurotoxins, 1-methyl-4-phenylpyridinuim ion, 6-hydroxydopamine, rotenone, and 1-benzyl-1,2,3,4-tetrahydroisoquinoline, in cultured rat mesencephalic neurons. 1MeTIQ exerted neuroprotective action against all these toxins. Furthermore, (R)-1MeTIQ was neuroprotective, while (S)-1MeTIQ had little effect, indicating that the effect is stereoselective. The protective action of 1MeTIQ was most effective in mesencephalic neurons, especially in tyrosine hydroxylase-positive neurons. 1MeTIQ showed no affinity for dopamine receptors and did not influence the inhibition of mitochondrial respiratory complex I by rotenone, 1-methyl-4-phenylpyridinuim ion, or 1-benzyl-1,2,3,4-tetrahydroisoquinoline. These results raise the possibility that 1MeTIQ indirectly acts as an anti-oxidant such as the induction of anti-oxidative enzymes, because all these four neurotoxins can burden oxidative stress in common. This is the first report to confirm a protective effect of 1MeTIQ at the cultured neuron level, and it may have potential as a lead compound for the development of new agents to treat Parkinson's disease. (C) 2005 Elsevier B.V All rights reserved.

DOI： 10.1016/j.brainres.2004.11.019

Web of Science

PubMed

researchmap

Language：English   Publishing type：Research paper (scientific journal)   Publisher：ELSEVIER SCIENCE BV  

In Guadeloupe, the French West Indies, there is a high incidence of atypical parkinsonism or progressive supranuclear palsy, and all of the investigated patients had taken herbal tea or tropical fruits of the Annonaceae family. Local inhabitants consume the fruits, and also drink tea made from the leaves. In the present study, we used liquid chromatography-tandem mass spectrometry (LC/MS/MS) with multiple reaction monitoring (MRM) to detect low-molecular-weight neurotoxic benzylisoquinoline derivatives in the Annonaceae family. We detected reticuline and N-methylcoculaurine in every Annona muricata sample examined, except for pulp and seed. They were not detected in sweetsop fruits. Norreticuline was not detected in any sample. These three compounds were toxic to SH-SY5Y neuroblastoma cells and inhibited mitochondrial respiratory complex I. It is possible that uptake of the benzylisoquinoline derivatives reticuline and N-methylcoculaurine and their accumulation in the brain may be related to the pathogenesis of the local endemic disease. (C) 2004 Elsevier B.V. All rights reserved.

DOI： 10.1016/j.jchromb.2004.03.017

Web of Science

PubMed

researchmap

Event date： 2023.1

Language：Japanese   Presentation type：Oral presentation (general)  

researchmap

Event date： 2022.10

Language：Japanese   Presentation type：Oral presentation (general)  

researchmap

Event date： 2022.6

Language：Japanese   Presentation type：Oral presentation (general)  

researchmap

Event date： 2022.6

Language：Japanese   Presentation type：Poster presentation  

researchmap

Event date： 2022.1

Language：Japanese   Presentation type：Oral presentation (general)  

researchmap

Event date： 2021.10

Language：Japanese   Presentation type：Oral presentation (general)  

researchmap

Event date： 2021.9

Language：Japanese   Presentation type：Poster presentation  

researchmap

Event date： 2021.9

Language：English   Presentation type：Poster presentation  

researchmap

Event date： 2021.3

Language：Japanese   Presentation type：Oral presentation (general)  

researchmap

Event date： 2020.11

Language：Japanese   Presentation type：Oral presentation (general)  

researchmap

Event date： 2020.10

Language：Japanese   Presentation type：Oral presentation (general)  

researchmap

Event date： 2020.10

Language：Japanese   Presentation type：Oral presentation (general)  

researchmap

Event date： 2020.10

Language：Japanese   Presentation type：Oral presentation (general)  

researchmap

Event date： 2020.6

Language：Japanese   Presentation type：Oral presentation (general)  

researchmap

Event date： 2020.6

Language：Japanese   Presentation type：Poster presentation  

researchmap

Event date： 2020.6

Language：Japanese   Presentation type：Poster presentation  

researchmap

Event date： 2020.6

Language：Japanese   Presentation type：Poster presentation  

researchmap

Event date： 2019.11

Language：Japanese   Presentation type：Oral presentation (general)  

researchmap

Event date： 2019.11

Language：Japanese   Presentation type：Oral presentation (general)  

researchmap

Event date： 2019.11

Language：Japanese   Presentation type：Oral presentation (general)  

researchmap

Event date： 2019.11

Language：Japanese   Presentation type：Oral presentation (general)  

researchmap

Event date： 2019.10

Language：Japanese   Presentation type：Oral presentation (general)  

researchmap

Event date： 2019.7

Language：Japanese   Presentation type：Poster presentation  

researchmap

Event date： 2019.6

Language：Japanese   Presentation type：Poster presentation  

researchmap

Event date： 2019.6

Language：Japanese   Presentation type：Symposium, workshop panel (nominated)  

researchmap

Event date： 2019.6

Language：Japanese   Presentation type：Symposium, workshop panel (nominated)  

researchmap

Event date： 2019.6

Language：Japanese   Presentation type：Oral presentation (general)  

researchmap

Event date： 2019.6

Language：Japanese   Presentation type：Poster presentation  

researchmap

Event date： 2019.6

Language：Japanese   Presentation type：Poster presentation  

researchmap

Event date： 2019.6

Language：Japanese   Presentation type：Poster presentation  

researchmap

Event date： 2019.6

Language：Japanese   Presentation type：Poster presentation  

researchmap

Event date： 2019.6

Language：Japanese   Presentation type：Oral presentation (general)  

researchmap

Event date： 2019.6

Language：Japanese   Presentation type：Poster presentation  

researchmap

Event date： 2019.3

Language：Japanese   Presentation type：Poster presentation  

researchmap

Event date： 2019.1

Language：Japanese   Presentation type：Oral presentation (general)  

researchmap

Event date： 2018.12

Language：Japanese   Presentation type：Oral presentation (general)  

researchmap

Event date： 2018.11

Language：Japanese   Presentation type：Oral presentation (general)  

researchmap

Event date： 2018.9

Language：Japanese   Presentation type：Oral presentation (general)  

researchmap

Event date： 2018.9

Language：Japanese   Presentation type：Oral presentation (general)  

researchmap

Event date： 2018.9

Language：Japanese   Presentation type：Oral presentation (general)  

researchmap

Event date： 2018.9

Language：Japanese   Presentation type：Oral presentation (general)  

researchmap

Event date： 2018.9

Language：Japanese   Presentation type：Oral presentation (general)  

researchmap

Event date： 2018.7

Language：Japanese   Presentation type：Poster presentation  

researchmap

Event date： 2018.7

Language：Japanese   Presentation type：Poster presentation  

researchmap

Event date： 2018.7

Language：Japanese   Presentation type：Poster presentation  

researchmap

Event date： 2018.6

Language：English   Presentation type：Poster presentation  

researchmap

Event date： 2018.6

Language：English   Presentation type：Poster presentation  

researchmap

Event date： 2018.6

Language：English   Presentation type：Poster presentation  

researchmap

Event date： 2018.6

Language：English   Presentation type：Poster presentation  

researchmap

Event date： 2018.6

Language：English   Presentation type：Poster presentation  

researchmap

Event date： 2018.6

Language：English   Presentation type：Oral presentation (general)  

researchmap

Event date： 2018.6

Language：English   Presentation type：Poster presentation  

researchmap

Event date： 2018.6

Language：English   Presentation type：Poster presentation  

researchmap

Event date： 2018.4

Language：English   Presentation type：Poster presentation  

researchmap

Event date： 2018.3

Language：Japanese   Presentation type：Oral presentation (general)  

researchmap

Event date： 2018.1

Language：Japanese   Presentation type：Oral presentation (general)  

researchmap

Event date： 2018.1

Language：Japanese   Presentation type：Oral presentation (general)  

researchmap

Event date： 2017.11

Language：Japanese   Presentation type：Oral presentation (general)  

researchmap

Event date： 2017.11

Language：Japanese   Presentation type：Oral presentation (general)  

researchmap

Event date： 2017.11

Language：English   Presentation type：Poster presentation  

researchmap

Event date： 2017.11

Language：Japanese   Presentation type：Oral presentation (general)  

researchmap

Event date： 2017.10

Language：Japanese   Presentation type：Oral presentation (general)  

researchmap

Event date： 2017.10

Language：Japanese   Presentation type：Oral presentation (general)  

researchmap

Event date： 2017.10

Language：Japanese   Presentation type：Oral presentation (general)  

researchmap

Event date： 2017.9

Language：English   Presentation type：Poster presentation  

researchmap

Event date： 2017.9

Language：Japanese   Presentation type：Oral presentation (general)  

researchmap

Event date： 2017.8

Language：English   Presentation type：Poster presentation  

researchmap

Event date： 2017.7

Language：Japanese   Presentation type：Oral presentation (general)  

researchmap

Event date： 2017.6 - 2017.7

Language：Japanese   Presentation type：Oral presentation (invited, special)  

researchmap

Event date： 2017.6

Language：Japanese   Presentation type：Poster presentation  

researchmap

Event date： 2017.6

Language：Japanese   Presentation type：Poster presentation  

researchmap

Event date： 2017.6

Language：Japanese   Presentation type：Oral presentation (general)  

researchmap

Event date： 2017.6

Language：Japanese   Presentation type：Poster presentation  

researchmap

Event date： 2017.3

Language：Japanese   Presentation type：Oral presentation (invited, special)  

researchmap

Event date： 2016.12

Language：Japanese   Presentation type：Oral presentation (general)  

researchmap

Event date： 2016.11 - 2016.12

Language：Japanese   Presentation type：Poster presentation  

researchmap

Event date： 2016.10

Language：Japanese   Presentation type：Oral presentation (general)  

researchmap

Event date： 2016.10

Language：Japanese   Presentation type：Oral presentation (general)  

researchmap

Event date： 2016.10

Language：Japanese   Presentation type：Oral presentation (general)  

researchmap

Event date： 2016.10

Language：Japanese   Presentation type：Oral presentation (general)  

researchmap

Event date： 2016.10

Language：Japanese   Presentation type：Poster presentation  

researchmap

Event date： 2016.9

Language：Japanese   Presentation type：Oral presentation (general)  

researchmap

Event date： 2016.9

Language：Japanese   Presentation type：Oral presentation (general)  

researchmap

Event date： 2016.7

Language：Japanese   Presentation type：Oral presentation (general)  

researchmap

Event date： 2016.7

Language：Japanese   Presentation type：Poster presentation  

researchmap

Event date： 2016.6

Language：Japanese   Presentation type：Poster presentation  

researchmap

Event date： 2016.6

Language：Japanese   Presentation type：Poster presentation  

researchmap

Event date： 2016.6

Language：Japanese   Presentation type：Oral presentation (general)  

researchmap

Event date： 2016.6

Language：Japanese   Presentation type：Poster presentation  

researchmap

Event date： 2016.3

Language：Japanese   Presentation type：Poster presentation  

researchmap

Event date： 2016.3

Language：Japanese   Presentation type：Poster presentation  

researchmap

Event date： 2016.3

Language：Japanese   Presentation type：Oral presentation (general)  

researchmap

Event date： 2015.11

Language：Japanese   Presentation type：Oral presentation (general)  

researchmap

Event date： 2015.11

Language：Japanese   Presentation type：Oral presentation (general)  

researchmap

Event date： 2015.11

Language：Japanese   Presentation type：Oral presentation (general)  

researchmap

Event date： 2015.11

Language：Japanese   Presentation type：Oral presentation (general)  

researchmap

Event date： 2015.10

Language：Japanese   Presentation type：Oral presentation (general)  

researchmap

Event date： 2015.10

Language：Japanese   Presentation type：Oral presentation (general)  

researchmap

Event date： 2015.10

Language：Japanese   Presentation type：Oral presentation (general)  

researchmap

Event date： 2015.10

Language：Japanese   Presentation type：Oral presentation (general)  

researchmap

Event date： 2015.10

Language：Japanese   Presentation type：Oral presentation (general)  

researchmap

Event date： 2015.10

Language：Japanese   Presentation type：Oral presentation (general)  

researchmap

Event date： 2015.10

Language：English   Presentation type：Poster presentation  

researchmap

Event date： 2015.10

Language：Japanese   Presentation type：Poster presentation  

researchmap

Event date： 2015.10

Language：Japanese   Presentation type：Oral presentation (general)  

researchmap

Event date： 2015.9

Language：Japanese   Presentation type：Oral presentation (general)  

researchmap

Event date： 2015.9

Language：Japanese   Presentation type：Oral presentation (general)  

researchmap

Event date： 2015.9

Language：English   Presentation type：Poster presentation  

researchmap

Event date： 2015.7

Language：Japanese   Presentation type：Symposium, workshop panel (nominated)  

researchmap

Event date： 2015.6

Language：Japanese   Presentation type：Poster presentation  

researchmap

Event date： 2015.6

Language：Japanese   Presentation type：Poster presentation  

researchmap

Event date： 2015.6

Language：English   Presentation type：Poster presentation  

researchmap

Event date： 2015.6

Language：Japanese   Presentation type：Oral presentation (general)  

researchmap

Event date： 2015.6

Language：Japanese   Presentation type：Poster presentation  

researchmap

Event date： 2015.6

Language：Japanese   Presentation type：Poster presentation  

researchmap

Event date： 2015.6

Language：Japanese   Presentation type：Poster presentation  

researchmap

Event date： 2015.3

Language：Japanese   Presentation type：Oral presentation (general)  

researchmap

Event date： 2015.3

Language：Japanese   Presentation type：Poster presentation  

researchmap

Event date： 2015.3

Language：Japanese   Presentation type：Poster presentation  

researchmap

Event date： 2015.3

Language：Japanese   Presentation type：Oral presentation (general)  

researchmap

Event date： 2015.3

Language：Japanese   Presentation type：Oral presentation (general)  

researchmap

Event date： 2014.10 - 2014.11

Language：Japanese   Presentation type：Oral presentation (general)  

researchmap

Event date： 2014.10 - 2014.11

Language：Japanese   Presentation type：Oral presentation (general)  

researchmap

Event date： 2014.6

Language：Japanese   Presentation type：Oral presentation (general)  

researchmap

Event date： 2014.6

Language：English   Presentation type：Poster presentation  

researchmap

Event date： 2014.6

Language：English   Presentation type：Poster presentation  

researchmap

Event date： 2014.6

Language：English   Presentation type：Poster presentation  

researchmap

Event date： 2014.6

Language：English   Presentation type：Poster presentation  

researchmap

Event date： 2014.3

Language：Japanese   Presentation type：Poster presentation  

researchmap

Event date： 2014.3

Language：Japanese   Presentation type：Poster presentation  

researchmap

Event date： 2014.3

Language：Japanese   Presentation type：Oral presentation (general)  

researchmap

Event date： 2013.11

Language：Japanese   Presentation type：Poster presentation  

researchmap

Event date： 2013.10

Language：English   Presentation type：Poster presentation  

researchmap

Event date： 2013.9

Language：English   Presentation type：Poster presentation  

researchmap

Event date： 2013.9

Language：Japanese   Presentation type：Poster presentation  

researchmap

Event date： 2013.9

Language：Japanese   Presentation type：Poster presentation  

researchmap

Event date： 2013.9

Language：Japanese   Presentation type：Poster presentation  

researchmap

Event date： 2013.6

Language：Japanese   Presentation type：Oral presentation (general)  

researchmap

Event date： 2013.3

Language：Japanese   Presentation type：Poster presentation  

researchmap

Event date： 2013.3

Language：Japanese   Presentation type：Oral presentation (general)  

researchmap

Event date： 2012.11

Language：Japanese   Presentation type：Oral presentation (general)  

researchmap

Event date： 2012.6

Language：Japanese   Presentation type：Poster presentation  

researchmap

Event date： 2012.3

Language：Japanese   Presentation type：Oral presentation (general)  

researchmap

Event date： 2012.3

Language：Japanese   Presentation type：Oral presentation (general)  

researchmap

Event date： 2012.3

Language：Japanese   Presentation type：Oral presentation (general)  

researchmap

Event date： 2012.3

Language：Japanese   Presentation type：Poster presentation  

researchmap

Event date： 2012.3

Language：Japanese   Presentation type：Oral presentation (general)  

researchmap

Event date： 2011.11

Language：Japanese   Presentation type：Poster presentation  

researchmap

Event date： 2011.11

Language：English   Presentation type：Poster presentation  

researchmap

Event date： 2011.11

Language：English   Presentation type：Poster presentation  

researchmap

Event date： 2011.10

Language：Japanese   Presentation type：Poster presentation  

researchmap

Event date： 2011.7

Language：Japanese   Presentation type：Poster presentation  

researchmap

Event date： 2010.11

Language：English   Presentation type：Poster presentation  

researchmap

Event date： 2010.10

Language：English   Presentation type：Poster presentation  

researchmap

Event date： 2010.10

Language：English   Presentation type：Poster presentation  

researchmap

Event date： 2010.3

Language：Japanese   Presentation type：Poster presentation  

researchmap

Event date： 2009.10

Language：Japanese   Presentation type：Poster presentation  

researchmap

Event date： 2009.3

Language：Japanese   Presentation type：Poster presentation  

researchmap

Event date： 2009.3

Language：Japanese   Presentation type：Poster presentation  

researchmap

Event date： 2008.10

Language：Japanese   Presentation type：Poster presentation  

researchmap

Event date： 2008.3

Language：Japanese   Presentation type：Poster presentation  

researchmap

Event date： 2008.3

Language：Japanese   Presentation type：Poster presentation  

researchmap

Event date： 2008.3

Language：Japanese   Presentation type：Poster presentation  

researchmap

Event date： 2007.9

Language：Japanese   Presentation type：Poster presentation  

researchmap

Event date： 2007.9

Language：Japanese   Presentation type：Poster presentation  

researchmap

Event date： 2007.3

Language：Japanese   Presentation type：Poster presentation  

researchmap

Event date： 2007.3

Language：Japanese   Presentation type：Poster presentation  

researchmap

Event date： 2006.10

Language：Japanese   Presentation type：Poster presentation  

researchmap

Event date： 2006.3

Language：Japanese   Presentation type：Poster presentation  

researchmap

Event date： 2006.3

Language：Japanese   Presentation type：Poster presentation  

researchmap

Event date： 2005.10

Language：English   Presentation type：Poster presentation  

researchmap

Event date： 2005.10

Language：Japanese   Presentation type：Poster presentation  

researchmap

Event date： 2005.10

Language：Japanese   Presentation type：Poster presentation  

researchmap

Event date： 2005.10

Language：Japanese   Presentation type：Poster presentation  

researchmap

Event date： 2005.9

Language：Japanese   Presentation type：Poster presentation  

researchmap

Event date： 2005.3

Language：Japanese   Presentation type：Poster presentation  

researchmap

Event date： 2004.3

Language：Japanese   Presentation type：Poster presentation  

researchmap

Event date： 2003.10

Language：English   Presentation type：Poster presentation  

researchmap

Event date： 2003.10

Language：Japanese   Presentation type：Poster presentation  

researchmap

Event date： 2003.9

Language：Japanese   Presentation type：Poster presentation  

researchmap

Event date： 2003.3

Language：Japanese   Presentation type：Poster presentation  

researchmap

Event date： 2003.3

Language：Japanese   Presentation type：Poster presentation  

researchmap

Event date： 2003.3

Language：Japanese   Presentation type：Poster presentation  

researchmap

Event date： 2002.3

Language：Japanese   Presentation type：Poster presentation  

researchmap

Event date： 2002.3

Language：Japanese   Presentation type：Poster presentation  

researchmap

Event date： 2002.3

Language：Japanese   Presentation type：Poster presentation  

researchmap

Event date： 2002.3

Language：Japanese   Presentation type：Poster presentation  

researchmap

Event date： 2001.10

Language：English   Presentation type：Poster presentation  

researchmap

Event date： 2001.9

Language：Japanese   Presentation type：Poster presentation  

researchmap

Event date： 2001.3

Language：Japanese   Presentation type：Poster presentation  

researchmap

Event date： 2000.10

Language：Japanese   Presentation type：Oral presentation (general)  

researchmap